137 related articles for article (PubMed ID: 24578900)
1. Efficacy of combination therapy with tamsulosin and zolpidem on nocturia in patients with benign prostatic hyperplasia.
Miwa K; Nishino Y; Kikuchi M; Masue T; Moriyama Y; Deguchi T
Cent European J Urol; 2011; 64(4):232-5. PubMed ID: 24578900
[TBL] [Abstract][Full Text] [Related]
2. The effect of combined therapy with tamsulosin hydrochloride and meloxicam in patients with benign prostatic hyperplasia symptoms and impact on nocturia and sleep quality.
Gorgel SN; Sefik E; Kose O; Olgunelma V; Sahin E
Int Braz J Urol; 2013; 39(5):657-62. PubMed ID: 24267123
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and safety of oral Tamsulosin controlled absorption system (OCAS) for the treatment of lower urinary tract symptoms due to bladder outlet obstruction associated with benign prostatic hyperplasia: an open-label preliminary study.
Lojanapiwat B; Permpongkosol S
Int Braz J Urol; 2011; 37(4):468-76. PubMed ID: 21888698
[TBL] [Abstract][Full Text] [Related]
4. Correlations among Lower Urinary Tract Symptoms, Bother, and Quality of Life in Patients with Benign Prostatic Hyperplasia and Associated Fluctuations with Tamsulosin Administration.
Gotoh M; Matsukawa Y; Funahashi Y; Kato M; Maseki Y; Narita H; Kamihira O; Hattori R
Low Urin Tract Symptoms; 2012 Jan; 4(1):45-50. PubMed ID: 26676459
[TBL] [Abstract][Full Text] [Related]
5. Effect of tamsulosin hydrochloride on lower urinary tract symptoms and quality of life in patients with benign prostatic hyperplasia. Evaluation using bother score.
Yoshida M; Sugiyama Y; Masunaga K; Maeda Y; Satoji Y; Nagata T; Inadome A
Drugs Today (Barc); 2007 Jun; 43 Suppl B():1-7. PubMed ID: 17612712
[TBL] [Abstract][Full Text] [Related]
6. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
[TBL] [Abstract][Full Text] [Related]
7. The evaluation of nocturia in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and the analysis of the curative effect after medical or placebo therapy for nocturia: a randomized placebo-controlled study.
Xue Z; Lin Y; Jiang Y; Wei N; Bi J
BMC Urol; 2018 Dec; 18(1):115. PubMed ID: 30545338
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.
Nishino Y; Masue T; Miwa K; Takahashi Y; Ishihara S; Deguchi T
BJU Int; 2006 Apr; 97(4):747-51, discussion 751. PubMed ID: 16536766
[TBL] [Abstract][Full Text] [Related]
9. Ramelteon combined with an α1-blocker decreases nocturia in men with benign prostatic hyperplasia.
Kawahara T; Morita S; Ito H; Terao H; Sakata R; Ishiguro H; Tanaka K; Miyamoto H; Matsuzaki J; Kubota Y; Uemura H
BMC Urol; 2013 Jun; 13():30. PubMed ID: 23758651
[TBL] [Abstract][Full Text] [Related]
10. A comparative randomized prospective study to evaluate efficacy and safety of combination of tamsulosin and tadalafil vs. tamsulosin or tadalafil alone in patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
Singh DV; Mete UK; Mandal AK; Singh SK
J Sex Med; 2014 Jan; 11(1):187-96. PubMed ID: 24165272
[TBL] [Abstract][Full Text] [Related]
11. Effect of doxazosin gastrointestinal therapeutic system 4 mg vs tamsulosin 0.2 mg on nocturia in Chinese men with lower urinary tract symptoms: a prospective, multicenter, randomized, open, parallel study.
Zhang K; Yu W; Jin J; Ye H; Wang X; Zhang N; Yang Y; Zhong C; Wan B
Urology; 2011 Sep; 78(3):636-40. PubMed ID: 21696807
[TBL] [Abstract][Full Text] [Related]
12. The α1 adrenoceptor antagonist tamsulosin for the treatment of voiding symptoms improves nocturia and sleep quality in women.
Kim SO; Choi HS; Kwon D
Urol J; 2014 Jul; 11(3):1636-41. PubMed ID: 25015610
[TBL] [Abstract][Full Text] [Related]
13. Zolpidem pharmacotherapy combined with alpha-blocker therapy for nocturia unresponsive to alpha-blocker monotherapy in men with lower urinary tract symptoms: a preliminary study.
Song YS; Ku JH
Int Urol Nephrol; 2007; 39(4):1147-52. PubMed ID: 17610040
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Naftopidil 75 mg with Tamsulosin Hydrochloride 0.2 mg in the Treatment of Lower Urinary Tract Symptoms with Benign Prostatic Hyperplasia.
Shigemura K; Yamamichi F; Matsumoto M; Tanaka K; Yamashita M; Arakawa S; Fujisawa M
Low Urin Tract Symptoms; 2012 Sep; 4(3):136-9. PubMed ID: 26676620
[TBL] [Abstract][Full Text] [Related]
15. Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe.
Chapple CR; Montorsi F; Tammela TL; Wirth M; Koldewijn E; Fernández Fernández E;
Eur Urol; 2011 Mar; 59(3):342-52. PubMed ID: 21109344
[TBL] [Abstract][Full Text] [Related]
16. Male patients with a higher frequency of nocturnal urinary episodes are more likely to benefit from alpha-blocker therapy for bothersome nocturia.
Lee CL; Kuo HC
Low Urin Tract Symptoms; 2019 Apr; 11(2):O174-O179. PubMed ID: 30548822
[TBL] [Abstract][Full Text] [Related]
17. Impact of lower urinary tract symptoms/benign prostatic hyperplasia treatment with tamsulosin and solifenacin combination therapy on erectile function.
Seo DH; Kam SC; Hyun JS
Korean J Urol; 2011 Jan; 52(1):49-54. PubMed ID: 21344031
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey.
Suzuki H; Yano M; Awa Y; Nakatsu H; Egoshi K; Mikami K; Ota S; Okano T; Hamano S; Ohki T; Furuya Y; Ichikawa T
Int J Urol; 2006 Sep; 13(9):1202-6. PubMed ID: 16984553
[TBL] [Abstract][Full Text] [Related]
19. [Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe].
Chapple ChR; Montorsi F; Tammela TL; Wirth M; Koldewijn E; Fernandez Fernandez E
Urologiia; 2012; (5):38-42, 44-5. PubMed ID: 23342615
[TBL] [Abstract][Full Text] [Related]
20. Tamsulosin efficiency in treatment of benign prostatic hyperplasia evaluated by determining bladder weight.
Milicevic S
Med Arch; 2012; 66(6):391-5. PubMed ID: 23409519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
